Skip to main content

Primary Care Loop Closure Low Across All Test Types

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 29, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 28, 2023 -- Rates of loop closure are low for all test types across all primary care visit modalities but are worse for telehealth visits, according to a study published online Nov. 15 in JAMA Network Open.

Anthony Zhong, from Harvard Medical School in Boston, and colleagues examined the prevalence of diagnostic loop closure for tests and referrals ordered at telehealth visits versus in-person visits. The analysis included test and referral orders for 4,133 patient visits from March 1, 2020, to Dec. 31, 2021, at a large urban hospital-based primary care practice and one affiliated community health center.

The researchers found that 27.8 percent of orders were placed during a telehealth visit, and of the telehealth orders, 42.6 percent were completed within the designated time frame versus 58.4 percent of those ordered during in-person visits and 57.4 percent of those ordered without a visit. In the adjusted analysis, patients with telehealth visits were still less likely to close the loop for all test types versus those with in-person visits (odds ratio, 0.55).

"Failure to close diagnostic loops presents a patient safety challenge in primary care that may be of particular concern during telehealth encounters," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization

FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...

Breakthrough Gene Therapy Enables Infant Born Deaf to Hear

FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...

Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure

FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.